Myomo Inc.

04/10/2025 | Press release | Distributed by Public on 04/10/2025 12:27

Myomo Announces Upcoming Changes to its Board of Directors

BURLINGTON, Mass. (April 10, 2025) - Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that directors Amy Knapp and Yitzchak Jacobovitz have informed the board they will not stand for re-election as Class II directors. Ms. Knapp has been a director since July 2016 and Mr. Jacobovitz has served on Myomo's board since January 2023. Their terms will conclude as of the Company's 2025 Annual Meeting expected to be held in June 2025. Read more.

Myomo Inc. published this content on April 10, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 10, 2025 at 18:27 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]